IS1736B - Aðferð og tæki sem stuðla að aukinni samloðun agna - Google Patents

Aðferð og tæki sem stuðla að aukinni samloðun agna

Info

Publication number
IS1736B
IS1736B IS4214A IS4214A IS1736B IS 1736 B IS1736 B IS 1736B IS 4214 A IS4214 A IS 4214A IS 4214 A IS4214 A IS 4214A IS 1736 B IS1736 B IS 1736B
Authority
IS
Iceland
Prior art keywords
methods
devices
particle aggregation
agglomerates
promote increased
Prior art date
Application number
IS4214A
Other languages
English (en)
Other versions
IS4214A (is
Inventor
Trofast Eva
Olsson Magnus
Ahlneck Claes
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9303215A external-priority patent/SE9303215D0/xx
Priority claimed from SE9304270A external-priority patent/SE9304270D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of IS4214A publication Critical patent/IS4214A/is
Publication of IS1736B publication Critical patent/IS1736B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Disintegrating Or Milling (AREA)
  • Glanulating (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • External Artificial Organs (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Plant Substances (AREA)
IS4214A 1993-10-01 1994-09-28 Aðferð og tæki sem stuðla að aukinni samloðun agna IS1736B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303215A SE9303215D0 (sv) 1993-10-01 1993-10-01 Process II
SE9304270A SE9304270D0 (sv) 1993-12-22 1993-12-22 Process II

Publications (2)

Publication Number Publication Date
IS4214A IS4214A (is) 1995-04-02
IS1736B true IS1736B (is) 1999-12-30

Family

ID=26661852

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4214A IS1736B (is) 1993-10-01 1994-09-28 Aðferð og tæki sem stuðla að aukinni samloðun agna

Country Status (28)

Country Link
US (1) US6371171B1 (is)
EP (1) EP0721332B1 (is)
JP (1) JPH09504225A (is)
KR (1) KR100347497B1 (is)
CN (1) CN1119992C (is)
AT (1) ATE221371T1 (is)
AU (1) AU687896B2 (is)
BR (1) BR9407687A (is)
CA (1) CA2172055C (is)
CZ (1) CZ289394B6 (is)
DE (1) DE69431120T2 (is)
DK (1) DK0721332T3 (is)
EG (1) EG21071A (is)
ES (1) ES2178655T3 (is)
FI (1) FI117318B (is)
HU (1) HU226493B1 (is)
IL (1) IL111081A (is)
IS (1) IS1736B (is)
NO (1) NO316747B1 (is)
NZ (1) NZ274278A (is)
PL (1) PL175596B1 (is)
PT (1) PT721332E (is)
RU (1) RU2170083C2 (is)
SG (1) SG75091A1 (is)
SK (1) SK283554B6 (is)
TW (1) TW374728B (is)
UA (1) UA42736C2 (is)
WO (1) WO1995009616A1 (is)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) † 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
PL192441B1 (pl) 1997-03-20 2006-10-31 Schering Corp Sposób wytwarzania aglomeratów i postać dawkowania środka farmakologicznie aktywnego
US6182712B1 (en) 1997-07-21 2001-02-06 Inhale Therapeutic Systems Power filling apparatus and methods for their use
DE69924169T2 (de) * 1998-02-27 2006-02-02 Sandvik Intellectual Property Hb Verfahren und Vorrichtung zum tropfenförmigen Aufbringen fliessfähiger Massen auf ein Transportband
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
HK1042234A1 (zh) 1999-04-13 2002-08-09 Nektar Therapeutics 向肺部施加乾粉配方以治疗不育症
JP4859320B2 (ja) 1999-10-29 2012-01-25 ネクター セラピューティックス 改良された分散性を有する乾燥粉末組成物
WO2002096549A1 (en) * 2001-05-29 2002-12-05 Spheriform Pty Ltd Agglomeration of fine particulate material
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
DK1699434T3 (da) * 2003-09-02 2011-05-30 Norton Healthcare Ltd Fremgangsmåde til fremstilling af et lægemiddel
US7192919B2 (en) 2004-01-07 2007-03-20 Stelios Tzannis Sustained release compositions for delivery of pharmaceutical proteins
KR20120131245A (ko) 2004-06-18 2012-12-04 노파르티스 아게 기관지 감염의 치료 방법
CN101239330B (zh) * 2007-02-09 2010-10-27 中国石油化工股份有限公司 微球形催化剂载体的制备方法
CA2703597A1 (en) * 2007-10-25 2009-04-30 Novartis Ag Powder conditioning of unit dose drug packages
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
JP5668317B2 (ja) * 2009-04-24 2015-02-12 大正製薬株式会社 プソイドエフェドリン含有製剤粒子
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
JP7712916B2 (ja) * 2019-09-24 2025-07-24 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 吸入用乾燥粉末製剤のための新規担体粒子
CN113695054B (zh) * 2021-09-26 2024-08-30 常州市神工造粒设备有限公司 颗粒钾肥磨圆除粉装置

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3335456A (en) * 1964-09-29 1967-08-15 Onoda Cement Co Ltd Pan-typed granulating machine
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE2350746C3 (de) * 1973-10-10 1978-08-31 Guenther Papenmeier Gmbh & Co Kg Maschinen- Und Apparatebau, 4930 Detmold Verfahren und Vorrichtungen zur Herstellung von Granulaten aus pulverformigem, körnigem oder teigigem Gut
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4039480A (en) * 1975-03-21 1977-08-02 Reynolds Metals Company Hollow ceramic balls as automotive catalysts supports
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4086060A (en) * 1976-10-22 1978-04-25 Jocelyn Dickson Disposable manipulative laboratory device for transferring biological fluids
US4496376A (en) * 1978-01-26 1985-01-29 Litton Systems, Inc. Variable area molecular sieve container having a thermal control system
US4316819A (en) * 1980-08-11 1982-02-23 Uop Inc. Technique to reduce the zeolite molecular sieve solubility in an aqueous system
AT366932B (de) * 1980-12-15 1982-05-25 Gergely Gerhard Vorrichtung zum mischen und granulieren von pulverfoermigen substanzen mit einer mittels eines ventilverschlusses angebrachten siebmaschine
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
PL135587B1 (en) * 1982-08-16 1985-11-30 Zabrzanska Fabryka Maszyn Gorniczych "Powen" Centrifugal dewatering screen
US4495308A (en) * 1983-03-04 1985-01-22 Chevron Research Company Two-region spherical catalysts
US4605173A (en) * 1984-04-04 1986-08-12 Edmonds Harvey A Size reduction machine
US4689297A (en) * 1985-03-05 1987-08-25 Miles Laboratories, Inc. Dust free particulate enzyme formulation
US4688610A (en) 1985-03-19 1987-08-25 Spiral Systems Inc. Apparatus for dispensing particulate agglomerating solids
US4655701A (en) * 1986-02-19 1987-04-07 Fuji Paudal Kabushiki Kaisha Granulating apparatus
GB8606762D0 (en) 1986-03-19 1986-04-23 Boots Co Plc Therapeutic agents
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
GB8711005D0 (en) * 1987-05-09 1987-06-10 British Petroleum Co Plc Chemical process
SU1762998A1 (ru) * 1989-10-17 1992-09-23 Белорусский Институт Инженеров Железнодорожного Транспорта Устройство дл уплотнени и гранулировани плохосыпучих материалов
DE59100388D1 (de) * 1990-01-29 1993-10-28 Ciba Geigy Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers.
US5547567A (en) * 1990-10-01 1996-08-20 Cps - Chemical Products & Services A/S Apparatus for washing-down serigraphical frames and filterpart for the apparatus
GB9027018D0 (en) 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
DE4105984A1 (de) 1991-02-26 1992-08-27 Deutsche Forsch Luft Raumfahrt Verfahren zur aufbereitung pulverfoermiger rohstoffe
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol

Also Published As

Publication number Publication date
RU2170083C2 (ru) 2001-07-10
FI117318B (fi) 2006-09-15
DE69431120T2 (de) 2002-11-28
AU7826294A (en) 1995-05-01
JPH09504225A (ja) 1997-04-28
CN1119992C (zh) 2003-09-03
DK0721332T3 (da) 2002-09-02
TW374728B (en) 1999-11-21
IL111081A0 (en) 1994-11-28
FI961431A0 (fi) 1996-03-29
UA42736C2 (uk) 2001-11-15
DE69431120D1 (de) 2002-09-05
CZ289394B6 (cs) 2002-01-16
FI961431L (fi) 1996-03-29
US6371171B1 (en) 2002-04-16
PT721332E (pt) 2002-10-31
KR100347497B1 (ko) 2002-12-26
CN1132477A (zh) 1996-10-02
PL313766A1 (en) 1996-07-22
BR9407687A (pt) 1997-02-04
AU687896B2 (en) 1998-03-05
WO1995009616A1 (en) 1995-04-13
SK39296A3 (en) 1997-06-04
ATE221371T1 (de) 2002-08-15
NO961291D0 (no) 1996-03-29
NO316747B1 (no) 2004-04-26
NZ274278A (en) 1997-07-27
SK283554B6 (sk) 2003-09-11
NO961291L (no) 1996-03-29
CA2172055A1 (en) 1995-04-13
HUT74518A (en) 1997-01-28
IL111081A (en) 1998-12-06
CA2172055C (en) 2005-11-08
EP0721332B1 (en) 2002-07-31
EG21071A (en) 2000-10-31
EP0721332A1 (en) 1996-07-17
SG75091A1 (en) 2000-09-19
IS4214A (is) 1995-04-02
HU226493B1 (en) 2009-03-02
ES2178655T3 (es) 2003-01-01
HU9600823D0 (en) 1996-05-28
PL175596B1 (pl) 1999-01-29
CZ94196A3 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
IS4214A (is) Aðferð og tæki sem stuðla að aukinni samloðun agna
HUT74519A (en) Process and apparatus for treatment of finely divided powdered medicament
GB9606677D0 (en) Process and device
NO943463L (no) Separator for pulverinhalatorer
HUT75136A (en) Medicament carrier for breathing activated, dry powder inhalator
YU18300A (sh) Perforisane mikročestice i postupci za njihovu primenu
DE3477738D1 (en) Electronic circuit detecting respiratory parameters in implantable devices, such as implantable and physiologic pacemakers
PL317225A1 (en) Drugs
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
ZA83321B (en) Method of,and arrangement for,reducing oxide-containing fine particle ores
DE69408122D1 (de) Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
CY1113221T1 (el) Διεργασια για την παρασκευη ενος φαρμακου
Klukowska et al. Acquired factor VIII inhibitor in a non‐haemophilic boy
Yaglo Texturing and ultrasound processing of magnetic powders
温景嵩 et al. The Coagulation Rate of Small Particles When Both Gravitational Convection and Brownian Motion Simultaneously Exist
IS4215A (is) Aðferð og tæki sem stuðla að aukinni samloðun agna
GB1507216A (en) Immunoregulatory preparation